ArticleMolecular cancer therapeutics2022

Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models.

Khanh B Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.